Hyd’s Virchow Biotech to make 200 million doses of Sputnik V

Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF), has joined hands with Bengaluru-based Strides Pharma’s biopharma division Stelis Biopharma Pvt Ltd to manufacture and supply at least 200 million doses of Russian Covid-19 vaccine Sputnik V.Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF), has joined hands with Bengaluru-based Strides Pharma’s biopharma division Stelis Biopharma Pvt Ltd to manufacture and supply at least 200 million doses of Russian Covid-19 vaccine Sputnik V.

Replica of Print on your device!